Skip to main content
OpenTrials

Clinical trial condition

Chronic Lymphocytic Leukemia

Explore clinical trials studying Chronic Lymphocytic Leukemia. Study availability and eligibility vary by location and protocol.

528 public trials 91 recruiting studies
Refine in advanced search Browse all conditions

Chronic Lymphocytic Leukemia trial results

Completed

Study to Evaluate Safety and Preliminary Efficacy of Tafasitamab With Idelalisib or Venetoclax in R/R CLL/SLL Patients Pretreated With BTKi

NCT02639910

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Clinical Study Site Jacksonville, Florida, United States
  • Clinical Study Site Rochester, Minnesota, United States
  • Clinical Study Site Columbus, Ohio, United States
  • Clinical Study Site Graz, Austria
View all 17 locations
View Trial Details
Completed

A Study of the Efficacy of ABT-199 in Subjects With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia With the 17p Deletion

NCT01889186

Conditions
17p Deletion, Cancer of the Blood and Bone Marrow, Chromosome 17 deletion, +17 more
Locations
  • University of Arizona Cancer Center - North Campus /ID# 96748 Tucson, Arizona, United States
  • City of Hope /ID# 112875 Duarte, California, United States
  • Moore UC San Diego Cancer Center /ID# 91793 La Jolla, California, United States
  • Stanford University School of Med /ID# 105117 Stanford, California, United States
View all 48 locations
View Trial Details
Completed

Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.

NCT01353625

Conditions
Astrocytoma, Blood Protein Disorders, Carcinoma, +52 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • UCLA Los Angeles, California, United States
  • University of California, San Francisco Comprehensive Cancer Center and Cancer Research Institiute San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 17 locations
View Trial Details
Completed

Clinical-biological Characteristics and Outcome of Chronic Lymphocytic Leukemia Under Ibrutinib-named Patient Program

NCT02582320

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • U.O.C. Ematologia e Terapia Cellulare - Ospedale "C. e G. Mazzoni" di Ascoli Piceno Ascoli Piceno, Italy
  • U.O.C di Ematologia P.O. "S.Giuseppe Moscati" - 2° piano Aversa, Italy
  • UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro Bari, Italy
  • Istituto di Ematologia "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi Bologna, Italy
View all 47 locations
View Trial Details
Completed

Evaluate the Safety and Efficacy of TGR 1202 in Patients With Relapsed or Refractory Hematologic Malignancies

NCT01767766

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +22 more
Locations
  • TG Therapeutics Trial Site Sarasota, Florida, United States
  • TG Therapeutics Trial Site Hackensack, New Jersey, United States
  • TG Therapeutics Trial Site New York, United States
  • TG Therapeutics Trial Site Durham, North Carolina, United States
View Trial Details

Related conditions